S3080-119

In Committee

Nitazene Sanctions Act

119th Congress Introduced Oct 30, 2025

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill expands the existing Fentanyl Sanctions Act to cover nitazenes, an extremely potent class of synthetic opioids produced primarily in China. It adds Chinese chemical companies and senior Chinese government officials to the sanctions framework if they are involved in or fail to prevent opioid precursor trafficking. It also extends the sanctions regime from 5 to 10 years.

Who Benefits and How

U.S. law enforcement and anti-drug agencies gain expanded tools to designate Chinese entities as foreign opioid traffickers and impose sanctions. Domestic pharmaceutical and chemical companies may benefit indirectly as Chinese competitors face sanctions. U.S. communities affected by the opioid crisis benefit from reduced supply of ultra-potent synthetic opioids.

Who Bears the Burden and How

Chinese chemical manufacturing companies that produce nitazene precursors face potential U.S. sanctions including asset freezes and exclusion from the U.S. financial system. Chinese government officials with regulatory oversight of these companies face personal sanctions if they aid or abet trafficking through intentional inaction. Foreign financial institutions owned by governments supporting opioid precursor trafficking face potential sanctions.

Key Provisions

  • Adds nitazenes (2-benzylbenzimidazole opioids) to the Fentanyl Sanctions Act coverage
  • Allows designation of Chinese chemical entities and senior government officials as foreign opioid traffickers
  • Extends sanctions authority under the Fentanyl Sanctions Act from 5 years to 10 years

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.

At a Glance

What This Bill Does

Expands the Fentanyl Sanctions Act to cover nitazene (2-benzylbenzimidazole opioids), targets Chinese chemical manufacturers and government officials involved in opioid precursor trafficking, and extends the sanctions regime from 5 to 10 years.

Key Policy Areas

National Security, Drug Enforcement, International Trade, Sanctions

Primary Purpose

Expands the Fentanyl Sanctions Act to cover nitazene (2-benzylbenzimidazole opioids), targets Chinese chemical manufacturers and government officials involved in opioid precursor trafficking, and extends the sanctions regime from 5 to 10 years.

Policy Domains

National Security Drug Enforcement International Trade Sanctions

Nitazene Sanctions Act

Identified Gains
Contextual inference, no direct clause citation
  • U.S. drug enforcement agencies (DEA)
  • Domestic pharmaceutical and chemical companies
  • U.S. communities affected by opioid crisis
Model: N/A | Version: bill_summary_v2 | Source: is

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • Chinese chemical manufacturing companies
  • Chinese government officials with narcotics oversight
  • Foreign financial institutions linked to opioid trafficking governments
Model: N/A | Version: bill_summary_v2 | Source: is

Contextual inference, no direct clause citation

Legislative Progress

In Committee
Introduced Committee Passed
Oct 30, 2025

Mr. Ricketts (for himself, Mr. Schmitt, and Mr. McCormick) introduced …

Oct 30, 2025

Read twice and referred to the Committee on Banking, Housing, …

Oct 30, 2025

Introduced in Senate

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Manufacturing
4 mentions across 4 clauses
-4 negative

Chinese chemical companies producing or financing opioid precursors, Chinese chemical manufacturing companies producing nitazene precursors, Foreign manufacturers and traffickers of nitazene and its precursors

Government
3 mentions across 3 clauses
+1 positive -2 negative

Senior Chinese government officials with narcotics oversight, U.S. State Department and Department of Justice, U.S. drug enforcement agencies

Positive-direction: U.S. drug enforcement agencies

Negative-direction: Senior Chinese government officials with narcotics oversight, U.S. State Department and Department of Justice

Depository Credit Intermediation
2 mentions across 1 clause
-2 negative

Chinese state-owned banks and financial institutions, Foreign government agencies and state-owned financial institutions involved in opioid precursor trafficking

6/7
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
National Security Drug Enforcement International Trade Sanctions
Actor Mappings
"the_president"
→ President of the United States
"the_secretary"
→ Secretary of State
"the_attorney_general"
→ Attorney General

Key Definitions

Terms defined in this bill

2 terms
"2-benzylbenzimidazole opioids (nitazenes)" §2_nitazenes

A class of synthetic opioids first synthesized in the 1950s that exhibit significant potency at the mu-opioid receptor, with some substances exceeding the potency of fentanyl.

"foreign opioid trafficker (expanded)" §5_foreign_opioid_trafficker_expanded

Expanded to include Chinese entities that produce, manufacture, distribute, sell, or finance opioid precursors and fail to take credible steps to prevent trafficking, as well as senior Chinese officials who aid and abet trafficking through intentional inaction.

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology